This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2018 Remove Healthcare Provider Remove Pharmacology Related Topics
Side effects Prescription Food and Drug Administration Healthcare Prospecting Physicians Biopharma Patients FDA Leads More Related Topics >
article thumbnail

The potential of virtual reality-based therapy for serious mental disorders

Pharmaceutical Technology

AUGUST 12, 2022

The FDA’s breakthrough device programme is for medical devices or device-led combination products that provide more effective treatment or diagnosis of diseases. The aim of the programme is to expedite the development, assessment and review of medical devices in order to provide timely access to patients and healthcare providers.

Food and Drug Administration 141
Food and Drug Administration Pharmacology Side effects Physicians 141
article thumbnail

Understanding a rare disease through the lens of real world and prevalence data

Clarivate

FEBRUARY 28, 2023

annually in the claims dataset for the period of 2018-2021. Our analysis included prescription trends for antibiotics, steroids, vitamins and ophthalmic-intraocular pressure reducing agents (prostaglandin analogs and alpha-adrenergic agonists) from 2018 to 2021. Frontiers in Pharmacology; 13:1089033; DOI: 10.3389/fphar.2022.1089033

Prescription 98
Prescription Patients Pharmacology Healthcare 98
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024